☆ 4.7 Article

Single-center experience on progressive multifocal leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU)

JOURNAL OF MEDICAL VIROLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Immunology

Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis

Shitiz Sriwastava et al.

Summary: Younger age and lower JCV viral load at the time of PML diagnosis were associated with better outcomes in MS-associated PML, while no specific PML therapy was found to be superior or associated with favorable outcomes.

JOURNAL OF NEUROIMMUNOLOGY (2021)

Add to Collection

Article Clinical Neurology

Clinical Presentation and Disease Course of 37 Consecutive Cases of Progressive Multifocal Leukoencephalopathy (PML) at a German Tertiary-Care Hospital: A Retrospective Observational Study

Lisa M. Graf et al.

Summary: This study conducted at a German tertiary-care hospital focused on patients with PML, revealing that HIV-1 was the leading cause of PML and most patients had underlying immunosuppressive disorders. Treatment attempts to improve outcomes were reported in 35% of patients, with a 24-month survival rate of 56%.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML

Manel Alleg et al.

Summary: The study compared brain MRI findings in PML associated with rituximab, natalizumab treatments, and HIV infection. Different imaging features were observed in the three types of PML, with natalizumab-associated PML showing more inflammatory signs and cortex involvement, while rituximab and HIV-associated PML exhibited milder contrast enhancement and punctuate appearance. The differences in MRI findings may be related to varying levels of immunosuppression in the different patient groups.

EUROPEAN RADIOLOGY (2021)

Add to Collection

Correction Clinical Neurology

Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned (vol 17, pg 467, 2018)

E. O. Major et al.

LANCET NEUROLOGY (2018)

Add to Collection

Article Clinical Neurology

Progressive Multifocal Leukoencephalopathy

Elena Grebenciucova et al.

NEUROLOGIC CLINICS (2018)

Add to Collection

Review Clinical Neurology

Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned

Eugene O. Major et al.

LANCET NEUROLOGY (2018)

Add to Collection

Review Clinical Neurology

Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies

Eric M. L. Williamson et al.

NEUROTHERAPEUTICS (2017)

Add to Collection

Article Clinical Neurology

Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases

Roderick P. P. W. M. Maas et al.

JOURNAL OF NEUROLOGY (2016)

Add to Collection

Review Clinical Neurology

PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section

Joseph R. Berger et al.

NEUROLOGY (2013)

Add to Collection

Article Immunology

Progressive Multifocal Leukoencephalopathy (PML) Development Is Associated With Mutations in JC Virus Capsid Protein VP1 That Change Its Receptor Specificity

Leonid Gorelik et al.

JOURNAL OF INFECTIOUS DISEASES (2011)

Add to Collection

Article Immunology

Progressive multifocal leukoencephalopathy

Robert Weissert

JOURNAL OF NEUROIMMUNOLOGY (2011)

Add to Collection

Review Clinical Neurology

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

Chen S. Tan et al.

LANCET NEUROLOGY (2010)

Add to Collection

Article Immunology

Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study

Frederik Neess Engsig et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

Add to Collection

Review Infectious Diseases

Progressive multifocal leukoencephalopathy in HIV-1 infection

Paola Cinque et al.

LANCET INFECTIOUS DISEASES (2009)

Add to Collection

Article Immunology

The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases

Eric J. Boren et al.

JOURNAL OF AUTOIMMUNITY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.